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Abstract
In a shotgun proteomics experiment, proteins are the most biologically meaningful output.
The success of proteomics studies depends on the ability to accurately and efficiently identify
proteins. Many methods have been proposed to facilitate the identification of proteins from
the results of peptide identification. However, the relationship between protein identification
and peptide identification has not been thoroughly explained before.
In this paper, we are devoted to a combinatorial perspective of the protein inference prob-
lem. We employ combinatorial mathematics to calculate the conditional protein probabil-
ities (Protein probability means the probability that a protein is correctly identified) under
three assumptions, which lead to a lower bound, an upper bound and an empirical estimation
of protein probabilities, respectively. The combinatorial perspective enables us to obtain a
closed-form formulation for protein inference.
Based on our model, we study the impact of unique peptides and degenerate peptides
on protein probabilities. Here, degenerate peptides are peptides shared by at least two pro-
teins. Meanwhile, we also study the relationship of our model with other methods such as
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ProteinProphet. A probability confidence interval can be calculated and used together with
probability to filter the protein identification result. Our method achieves competitive results
with ProteinProphet in a more efficient manner in the experiment based on two datasets of
standard protein mixtures and two datasets of real samples.
We name our program ProteinInfer. Its Java source code is available at:
http://bioinformatics.ust.hk/proteininfer
Introduction
Proteomics is developed to study the gene and cellular function directly at the protein level.1
In proteomics, mass spectrometry has been a primary tool in conducting high-throughput experi-
ments. In a typical shotgun proteomic experiment, proteins are digested into peptides by enzymes
and analyzed by a mass spectrometry to generate single stage mass spectra.1–3 Some peptides are
fragmented into smaller ions and analyzed to produce tandem mass spectra. Identifying peptides
from tandem mass spectra leads to the development of peptide identification methods.4–7 Protein
inference is to derive proteins from peptide identification. Conducting protein identification in an
accurate and high-throughput manner is a primary goal of proteomics.8,9
Quantitative measurement of protein identification confidence has been a major concern in
developing new protein inference models. The calculation of protein probability has become
popular as it provides nice properties in terms of distinction and accuracy:
• Distinction: Protein probability is a quantitative measurement of protein identification con-
fidence that different proteins are distinguishable based on their probabilities.
• Accuracy: By assigning each protein with a probability, we can have a statistical interpre-
tation of the protein identification result. Thus, the protein identification result can be more
reliable.
To date, many statistical models for protein probability calculation have been proposed.10 The
readers may refer to a recent review for detailed description on these methods.11 Depending on
the strategy to obtain protein probabilities, they can be grouped into the following two categories:
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• Probability Models: Methods in this category partitioned the degenerate peptide probability
among corresponding proteins. Degenerate peptides are peptides shared by at least two
proteins. Then, they calculated the probability of a protein as the probability that at least
one of its peptides was present. The partition weights were iteratively updated in an EM-
like algorithm.12–15
• Bayesian Methods: Methods in this group modeled the process of mass spectrometry in
a generative way by using the rigorous Bayesian framework.16–19 The Bayesian models
are complicated in their formulation. To obtain the solution, computational methods such
as Markov chain Monte Carlo (MCMC) are essential. More importantly, methods such
as MSBayesPro need extra information. The performance depends on the reliability of
extra information and the methods may not be applicable under different conditions. Fido
provides a way to calculate the marginal protein probability based on the Bayesian formula.
However, the computational complexity of the method is exponential with respect to the
number of distinct peptides.20
In this paper, we provide a combinatorial perspective of the protein inference problem to
calculate protein probabilities as well as to understand the probability partition procedure. Our
contributions can be described in the following aspects:
• By computing the marginal protein probability, we have a concise protein inference model
with an analytical solution, whose computational complexity is linear to the number of
distinct peptide.
• We deduce a lower bound and an upper bound of protein probability. Two bounds define
a probability confidence interval, which is used as an alternative factor other than protein
probability in filtering the protein identification result.
• The impacts of unique peptides and degenerate peptides are studied mathematically based
on our model. We also discuss some promising ways to further improve the distinction of
protein inference.
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• We discuss the connection of our method with other methods such as greedy methods and
ProteinProphet.12,21,22
The rest of our paper is organized as follows: Section 2 describes the details of our method;
Section 3 presents the experimental results; Section 4 discusses and concludes the paper.
Method
Figure 1: The data structure of a protein identification problem. We need to estimate protein
probabilities given peptides probabilities and peptide-protein mapping. In the figure, peptide 1
and peptide 2 are degenerate peptides whereas peptide 3 and peptide M are unique peptides.
Proteins 
1, 𝑃𝑟 =? 2, 𝑃𝑟 =? 
1, 𝑃𝑟 = 0.6 2, 𝑃𝑟 = 0.9 3, 𝑃𝑟 = 0.8 
Peptides 
… 
… 
𝑁, 𝑃𝑟 =? 
𝑀, 𝑃𝑟 = 0.7 
Input 
Output 
Peptides from the same protein are assumed to contribute independently to presence of the pro-
tein. The assumption relates to Naive Bayes, in which features of an object contribute indepen-
dently to the object. From the viewpoint of statistics, the independence assumption not only
simplifies the modeling procedure, but also leads to stable results when information such as the
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inner structure of data is insufficient. The presence and the absence of peptides from different
proteins are also independent.
Figure 1 shows the data structure of the protein inference problem. In a protein identification
result, there are many candidate proteins. For simplicity, we would like to focus on one protein
to keep our notations concise.
Suppose a protein has M peptides. We use Pr(y = 1) and Pr(y = 0) to denote the present
probability and absent probability of the protein, respectively. For peptide i, Pr(xi = 1) and
Pr(xi = 0) represent its present and absent probabilities, respectively. Let ni be the number of
proteins which share peptide i. When ni ≥ 2, peptide i is a degenerate peptide; otherwise, it is a
unique peptide. We use G = {i|xi = 1} and G¯ = {i|xi = 0} to denote the set of present peptide
indices and the set of absent peptide indices, respectively. For each pair of G and G¯ , we have
G ∪ G¯ = {1,2, ...,M}. When i ∈ G , it means that peptide i is present (i.e. xi = 1). Similarly, i ∈ G¯
means the absence of peptide i (i.e. xi = 0). Denote the set {xi|i ∈ G } and the set {xi|i ∈ G¯ }
as XG and XG¯ , respectively. The conditional probability of the absence of the protein given
peptides is denoted as Pr(y = 0|XG ,XG¯ ). Let Pr(XG ) and Pr(XG¯ ) be ∏i∈G Pr(xi) and ∏i∈G¯ Pr(xi),
respectively.
Each peptide of a protein is assumed to contribute independently to the protein. According to
the basic probability theorem, the probability of a protein being absent is calculated as:
Pr(y = 0) = ∑
x1∈{0,1}
∑
x2∈{0,1}
... ∑
xM∈{0,1}
Pr(y = 0|x1,x2, ...,xM)
M
∏
i=1
Pr(xi)
= ∑
XG ,XG¯
Pr(y = 0|XG ,XG¯ )Pr(XG )Pr(XG¯ ).
(1)
To calculate the protein probability given by equation (1), we need to calculate the conditional
probability Pr(y = 0|XG ,XG¯ ). Directly computing the protein probability based on equation (1),
we need 2M operations. In the following sections, we will provide a way to calculate the protein
probability with the number of operations that is linear with respect to M.
When G is empty:
Pr(y = 0|XG¯ ) = Pr(y = 0|x1 = 0,x2 = 0, ...,xM = 0) = 1. (2)
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When G is not empty, different assumptions lead to different results. In the following sections,
we calculate the conditional protein probabilities based on three different assumptions. These
three assumptions lead to an upper bound, a lower bound and an empirical estimation of protein
probability, respectively.
Conditional Probability Based on A Loose Assumption
A loose assumption supposes that, when peptide i is detected, all corresponding proteins are
present. In other words, this peptide is contributed by all corresponding proteins. This assumption
is related to the one-hit rule used in protein inference.23
When G is not empty, the corresponding protein must be present. Thus, the conditional absent
probability is:
Pr(y = 0|XG ,XG¯ ) = 0. (3)
The absent probability is calculated as:
Pr(y = 0) =
M
∏
i=1
Pr(xi = 0)+ ∑
XG ,XG¯ ,G 6=∅
Pr(y = 0|XG ,XG¯ )Pr(XG )Pr(XG¯ )
=
M
∏
i=1
Pr(xi = 0)
=
M
∏
i=1
(1−Pr(xi = 1)).
(4)
The loose assumption leads to an upper bound of the protein probability:
PrU(y = 1) = 1−
M
∏
i=1
(1−Pr(xi = 1)). (5)
Conditional Probability Based on A Strict Assumption
A strict assumption supposes that, if a peptide is detected, it only comes from one corresponding
protein containing the peptide. Or equivalently, the peptide occurs for just once. This concept is
mostly related to greedy protein inference methods, which iteratively select a protein that explains
most of remaining peptides and removes peptides that have been explained.21,22
6
When G is not empty, the total number of ways to explain observed peptides (i.e. peptides
with corresponding indices in G ) is given by:
Nt =∏
i∈G
(
ni
1
)
=∏
i∈G
ni. (6)
Here, ni is the number of proteins containing peptide i. When the protein is absent, the number
of times that peptide i is shared is decreased by 1. Then, the total number of ways to explain the
observed peptides is:
Na =∏
i∈G
(
ni−1
1
)
=∏
i∈G
(ni−1). (7)
The conditional probability is given by:
Pr(y = 0|XG ,XG¯ ) =
Na
Nt
=
∏i∈G (ni−1)
∏i∈G ni
. (8)
We can consider two special cases to get some intuitions from equation (8).
Case 1: If there is any unique peptide (i.e. ni = 1), then Pr(y = 0|XG ,XG¯ ) = 0. This indicates
that the protein must be present if the corresponding unique peptide is observed.
Case 2: Suppose G = {1} and G¯ = {2,3, ...,M}. If the first peptide is shared by an infinity
number of proteins (i.e. n1→ ∞), then we have:
Pr(y = 0|XG ,XG¯ ) = limn1→∞
n1−1
n1
= 1. (9)
Equation (9) indicates that, if the first peptide is shared by too many proteins, we cannot determine
exactly the corresponding protein. The probability of the absence of the protein is 1.
When the conditional probability (8) is applied, we have:
Pr(y = 0) = ∑
XG ,XG¯
Pr(y = 0|XG ,XG¯ )Pr(XG )Pr(XG¯ )
=
M
∏
i=1
(1− 1
ni
Pr(xi = 1)).
(10)
Details are available in our supplementary document.
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This assumption is very strict and leads to a lower bound of protein probability:
PrL(y = 1) = 1−
M
∏
i=1
(1− 1
ni
Pr(xi = 1)). (11)
Conditional Probability Based on A Mild Assumption
A mild assumption supposes that, all proteins containing the peptide may generate the peptide.
The presence of a peptide is contributed by either one or multiple proteins.
When G is not empty, the total number of ways to explain observed peptides (i.e. peptides
with corresponding indices in G ) is given by:
Nt =∏
i∈G
[
ni
∑
k=1
(
ni
k
)]
=∏
i∈G
(2ni−1). (12)
Here, ni is the number of proteins that share peptide i. When the protein is absent, the number of
times that peptide i is shared is ni−1. Thus, the number of ways to explain the peptides above is
given by:
Na =∏
i∈G
(2(ni−1)−1). (13)
Then, we have:
Pr(y = 0|XG ,XG¯ ) =
Na
Nt
=
∏i∈G (2(ni−1)−1)
∏i∈G (2ni−1)
. (14)
Similarly, let us consider two special cases to get some insights from equation (14).
Case 1: If there is any unique peptide (i.e. ni = 1), then Pr(y = 0|XG ,XG¯ )) = 0. The corre-
sponding protein must be present to explain this unique peptide.
Case 2: Suppose G = {1} and G¯ = {2,3, ...,M}. If the first peptide is shared by an infinity
number of number of proteins (i.e. n1→ ∞), then we have:
Pr(y = 0|XG ,XG¯ ) = limn1→∞
2(n1−1)−1
2n1−1 =
1
2
. (15)
Equation (15) has a meaningful interpretation. If peptide 1 is shared by an infinity number of
proteins, determining the presence of a corresponding protein is like random guessing. The prob-
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abilities of the presence and absence of this protein are therefore both 0.5.
The strict assumption is exclusive. If a degenerate peptide has already been explained, other
proteins are not considered. In contrast, the mild assumption is inclusive. Explaining a degenerate
peptide with one protein will not affect the presence of other proteins containing this degenerate
peptide. Thus, we obtain different results in equation (9) and equation (15).
The absent probability based on the mild assumption reads:
Pr(y = 0) = ∑
XG ,XG¯
Pr(y = 0|XG ,XG¯ )Pr(XG )Pr(XG¯ )
=
M
∏
i=1
(1− 2
ni
2(2ni−1)Pr(xi = 1)).
(16)
The proof can be found in the supplementary document.
The assumption leads to an empirical estimation of protein probability:
PrE(y = 1) = 1−
M
∏
i=1
(1− 2
ni
2(2ni−1)Pr(xi = 1)). (17)
Marginal Protein Probability
The relationship of the three protein probabilities based on the three assumptions above is:
PrL(y = 1) = 1−
M
∏
i=1
(1− 1
ni
Pr(xi = 1))
≤ PrE(y = 1) = 1−
M
∏
i=1
(1− 2
ni
2(2ni−1)Pr(xi = 1))
≤ PrU(y = 1) = 1−
M
∏
i=1
(1−Pr(xi = 1)).
(18)
Here, ni≥ 1 is the number of times that peptide i is shared. Readers can refer to our supplementary
document for the proof. The closed-form inequality (18) can be used to calculate the lower
bound, the empirical estimation and the upper bound of protein probability efficiently. The total
numbers of operations to calculate PrL, PrE and PrU are linear with respect to the number of
distinct peptide. The equality is achieved when all peptides of the protein are unique peptides.
The empirical protein probability PrE(y = 1) is used as a major factor for measuring the protein
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identification confidence. The difference between the upper bound and the lower bound is:
PrD(y = 1) = PrU(y = 1)−PrL(y = 1). (19)
The difference PrD(y = 1) can be used to measure the confidence of the estimation. The smaller
the value of PrD(y = 1), the higher the confidence. When all peptides are unique, the probability
estimation has no ambiguity and PrD(y = 1) = 0. In this case, the confidence is the highest.
Different from exiting protein probability estimation methods, we have quantitative mea-
surements of protein identification confidence from different aspects. This makes it possible
to achieve superior distinction in the protein identification result.
Unique Peptides and Degenerate Peptides
Unique peptides play central roles in protein identification. We are more confident at the identi-
fication when more peptides from this protein are unique. According to our calculation (18), the
highest confidence of a protein is achieved when its peptides are all unique.
Degenerate peptides can increase the empirical protein probability PrE . However, the degree
of the increase depends on how many times the degenerate peptides are shared by other proteins.
To see this, let us consider a protein with unique peptide indices being {1,2, ...,M− 1} and a
degenerate peptide M. According to equation (16), we have:
Pr(y = 0) =
M
∏
i=1
(1− 2
ni
2(2ni−1)Pr(xi = 1))
=
M−1
∏
i=1
(1−Pr(xi = 1))(1− 2
nM
2(2nM −1)Pr(xM = 1))
≤
M−1
∏
i=1
Pr(xi = 0).
(20)
Thus, degenerate peptide M increases PrE :
PrE(y = 1) = 1−Pr(y = 0)≥ 1−
M−1
∏
i=1
Pr(xi = 0). (21)
The absent probability in equation (20) is monotonically increasing with respect to nM, which
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results in the monotonically decreasing in PrE .
Degenerate peptide M introduces ambiguity in protein probability estimation. The confidence
interval is given by:
PrD(y = 1) = PrU(y = 1)−PrL(y = 1)
=
M−1
∏
i=1
Pr(xi = 0)
[
nM−1
nM
Pr(xM = 1)
]
.
(22)
We can see that the ambiguity PrD increases when nM increases.
In conclusion, a degenerate peptide improves the empirical protein probability PrE and intro-
duces ambiguity in protein probability calculation (i.e. PrD 6= 0). As nM increases, the increase
in PrE becomes smaller and the confidence interval PrD becomes larger.
The Relationship with ProteinProphet
In our model, the loose assumption and the strict assumption relate to the one-hit rule and greedy
methods, respectively. In this section, we discuss the relationship of our method with Protein-
Prophet.
ProteinProphet calculates the protein probability as the probability that at least one of its
peptides is present. When processing a degenerate peptide, ProteinProphet apportions this peptide
among all proteins which share it. The protein with higher probability is assigned with more
weight. The probability of the absence of the protein is then formulated as:
Pr(y = 0) =
M
∏
i=1
(1−wiPr(xi = 1)). (23)
Here, wi is the weight assigned to peptide i of the protein. The assumption that the protein
is present when at least one of its peptide is present is questionable when degenerate peptides
are detected. Thus, ProteinProphet intuitively partitions the probability of degenerate peptide i
according to weight wi. Then, a dummy peptide with probability wiPr(xi) is assumed to be unique.
Dummy peptides together with original unique peptides are all unique. Under this situation, the
assumption that the protein is present if any peptide is detected is correct. This is because the
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protein must be present to explain its unique dummy or original peptides.
By comparing the ProteinProphet protein scoring function with our model (18), we can see
that they are very related. In the initial stage, ProteinProphet evenly apportions degenerate pep-
tides among all corresponding proteins (i.e. wi = 1ni ). That is exactly the lower bound PrL in
our model. At last, low confident proteins tend to occupy less weight whereas high confident
proteins tend to occupy more weight. Generally for high confident proteins, we have 1ni ≤ wi ≤ 1.
Thus, probabilities of these proteins estimated by ProteinProphet will be within the bound of our
model. Although ProteinProphet is not strictly originated from the basic probability theorem, its
formulation coincides with our model (18). This explains the popularity and good performance
of ProteinProphet in real applications.
Results
In this section, we first describe our experimental settings such as datasets and tools used in the
experiments. Then, we illustrate the unique peptide probability adjustment, which is a preprocess-
ing step in protein inference. Next, we explain the reporting format of our protein identification
result. Finally, we present and discuss the experimental results.
Experimental Settings
The evaluation of our method is conducted on four public available datasets: ISB, Sigma49,
Human and Yeast. The ISB dataset was generated from a standard protein mixture which contains
18 proteins.24 The sample was analyzed on a Waters/Micromass Q-TOF using an electrospray
source. The Sigma49 dataset was acquired by analyzing 49 standard proteins on a Thermo LTQ
instrument. The Human dataset was obtained by analyzing human blood serum samples with
Thermo LTQ. The Yeast dataset was obtained by analyzing cell lysate on both LCQ and ORBI
mass spectrometers from wild-type yeast grown in rich medium. The information of each dataset
is shown in Table 1.
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Table 1: Names and URLs of Data Files.
Dataset File Name URL
ISB QT20051230_S_18mix_04.mzXML
http://regis-web.systemsbiology.net
/PublicDatasets/
Sigma49 Lane/060121Yrasprg051025ct5.RAW
https://proteomecommons.org/
dataset.jsp?i=71610
Human PAe000330/021505_LTQ10401_1_2.mzXML
http://www.peptideatlas.org/
repository/
Yeast
YPD_ORBI/061220.zl.mudpit0.1.1/
raw/000.RAW http://aug.csres.utexas.edu/msnet/
When analyzing the ISB dataset and the Sigma49 dataset, we use the curve of false positives
versus true positives to evaluate the performance. The ground truth of the ISB dataset and the
Sigma49 dataset contains 18 and 49 proteins, respectively. A protein identification is a true
positive if it is from ground truth. Otherwise, the protein is a false positive. Given the same
number of false positives, more true positives mean a better performance. When analyzing the
Human dataset and the Yeast dataset, we prefer the curve of decoys versus targets because the
ground truth is not known in advance. Given the same number of decoys, the more the targets,
the better the performance. We also plot the curves of decoys versus targets for the ISB dataset
and the Sigma49 dataset.
The database we use is a target-decoy concatenated protein database, which contains 1048840
proteins. The decoys are obtained by reversing protein sequences of UniProtKB/Swiss-Prot (Re-
lease 2011_01). In our experiments, X!Tandem (Version 2010.10.01.1) is employed to identify
peptides from each dataset. In database search, the parameters “fragment monoisotopic mass
error”, “parent monoisotopic mass error plus” and “parent monoisotopic mass error minus” are
set to be 0.4Da, 2Da and 4Da, respectively. The number of missed cleavages permitted is 1.
Then, PeptideProphet and iProphet embedded in TPP (Version v4.5 RAPTURE rev 2, Build
201202031108 (MinGW)) are used to estimate peptide probabilities.25–27 At last, ProteinProphet
and our method are applied to estimate protein probabilities. The performance of ProteinProphet
is compared to that of our method.
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Adjust Unique Peptide Probabilities
Protein inference models take the peptide identification results as input. If the peptide probability
estimation is perfect, peptide probability adjustment is not essential. However, inferior peptide
probabilities always exist.
Unique peptides are important for protein identification. A confident misidentified unique
peptide (i.e. Pr(x = 1) = 0.99) will result in a high confident protein identification with a high
PrE and a low PrD. For example, if a tandem mass spectrum is matched to a decoy peptide, the
peptide is very likely to be unique. The unique high confident decoy peptide will lead the decoy
protein to be identified with a high confidence. This motivates the procedure of unique peptide
adjustment as a preprocessing step of our method.
Suppose a protein has m unique peptides. The adjusted unique peptide probability can be
calculated as:
Pr(xi = 1|m) = Pr(m|xi = 1)Pr(xi = 1)Pr(m|xi = 1)Pr(xi = 1)+Pr(m|xi = 0)Pr(xi = 0) . (24)
Here, peptide i is a unique peptide; Pr(xi = 1) is the probability that the unique peptide is true. The
terms Pr(m|xi = 1) and Pr(m|xi = 0) describe the probabilities of observing m unique peptides of
the protein when the unique peptide i is a true and a false identification, respectively. We model
Pr(m|xi = 1) and Pr(m|xi = 0) as Poisson distributions with different expected number of unique
peptides (i.e. λ1 and λ2):
Pr(m|xi = 1) = λ
m
1 e
−λ1
m!
Pr(m|xi = 0) = λ
m
2 e
−λ2
m!
. (25)
Generally, a true unique peptide tends to have more sibling unique peptides than a false unique
peptide on average. Thus, we have λ1 > λ2. In our program, these two parameters can be manu-
ally specified. Alternatively, these two parameters can be obtained empirically.
Suppose there are N candidate proteins and the number of unique peptides of protein j( j ∈
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{1,2, ...,N}) is m j. The empirical value of the expected value λ1 is estimated as:
λ1 =
∑Nj=1 I(m j ≥ 2)m j
∑Nj=1 I(m j ≥ 2)
. (26)
Here, I(·) is an indicator function with value being either 0 or 1.
Empirically, λ2 can be 1. It is common to observe that false proteins such as decoy proteins
to have a single unique peptide.
The adjusted unique peptide probability Pr(xi = 1|m) is used as the probability of peptide i in
our model (18).
The Protein Identification Result
There are three different kinds of relationships between two proteins:
• Indistinguishable: If two proteins contain exactly the same set of identified peptides, they
are indistinguishable. Indistinguishable proteins can be treated as a group.
• Subset: Identified peptides of a protein form a peptide set. If the peptide set of a protein is
the subset of the other, the former protein is a subset protein of the latter.
• Differentiable: Two proteins are differentiable if they both contain peptides those are not
from the other.
In the literature, subset proteins are generally discarded. However, it is not reasonable to
regard all subset proteins as being absent from a statistical point of view. Thus, we also calculate
the protein probability of subset proteins and organize our result in two separate files as shown
in Table 2. In the table, proteins 1 and 3 are indistinguishable proteins and protein 2 is a subset
protein of protein 1.
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Table 2: Subset and Non-subset Proteins.
Non-subset Proteins
Index Protein PrE PrL PrU PrD Other Proteins
1 1 PrE(y1) PrL(y1) PrU(y1) PrD(y1) 3
2 4 PrE(y4) PrL(y4) PrU(y4) PrD(y4) -
......
Subset Proteins
Index Protein PrE PrL PrU PrD Subset of Protein
1 2 PrE(y2) PrL(y2) PrU(y2) PrD(y2) 1
......
The empirical probability PrE and the bound PrD quantitatively describe the confidence of a
protein. Generally, a high PrE and a low PrD mean a confident protein. The identification result
is mainly sorted by the empirical protein probability PrE . In case two proteins have the same PrE ,
the order is then determined by PrD.
One purpose of protein identification is to select proteins to explain observed peptides. Subset
proteins do not increase the peptide explanation power. In general, we can perform downstream
analysis by only using non-subset proteins. However, according to the probability theorem, the
probability of a subset protein is not necessarily smaller than that of a non-subset protein. The
data explanation power and protein probability are totally two different kinds of things. Without
any prior knowledge, choosing proteins from data explanation’s viewpoint is safe. However, in
some cases, we may consider high confident subset proteins according to the prior knowledge
we have. For instance, the sample contains homogeneous proteins and it is possible that subset
proteins are present.
16
Figure 2: An example of the protein identification result. In the figure, there are two proteins
and three peptides with corresponding probabilities all being 0.9. Protein 2 is a subset protein
of protein 1. The probability PrE and the bound PrD are two quantitative measurements of the
confidence of a protein. The higher the value of PrE and the smaller the value of PrD, the more
confident the protein. Protein 1 is a confident protein with a high empirical probability PrE =
0.984 and a tight bound PrD = 0.029. For protein 2, there are two peptides present. Without
any prior knowledge, we cannot determine the presence of protein 2 mathematically. From the
data explanation’s aspect, we can report protein 1 only. Protein 2 can be considered if the protein
coverage is a concern and homogeneous proteins are known to be present.
Proteins 
1 2 
1, 𝑃𝑟 = 0.9 2, 𝑃𝑟 = 0.9 3, 𝑃𝑟 = 0.9 
Peptides 
Non-subset proteins 
Index Protein 𝑃𝑟𝐸 𝑃𝑟𝐿 𝑃𝑟𝑈 Other Proteins 𝑃𝑟𝐷 
1 1 0.984 0.970 0.999 0.029 - 
Subset proteins 
Index Protein 𝑃𝑟𝐸 𝑃𝑟𝐿 𝑃𝑟𝑈 Subset of Protein 𝑃𝑟𝐷 
1 2 0.840 0.698 0.990 0.292 1 
An example is shown in Figure 2 for the illustration purpose. Protein 1 is more confident than
protein 2. From data explanation’s viewpoint, protein 1 is present whereas protein 2 is absent.
This is because including protein 2 in the final protein list will not improve the data explanation
efficiency. When we know that homogeneous proteins are present and desire more proteins,
we can merge subset and non-subset proteins to obtain the final result by filtering proteins with
thresholds on PrE and PrD.
In our experiment, only non-subset proteins are considered in the comparison study.
17
Protein Identification Results on Four Datasets
Figure 3: Protein identification results on four datasets. In (a) and (b), the curves of false versus
true for the ISB dataset and the Sigma49 dataset are plotted; in (c) and (d), we show the curves
of decoy versus target for the ISB dataset and the Sigma49 dataset; in (e) and (f), the curves of
decoy versus target for the Human dataset and the Yeast dataset are shown. Considering that the
performances measured by different validation methods may differ from each other, we also draw
the curves of decoy versus target for the ISB dataset and the Sigma49 dataset.
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The protein identification results on four datasets are shown in Figure 3. Our method outperforms
ProteinProphet in Figure 3(a) and achieves a comparable result with ProteinProphet in Figure
3(b). When using the curve of the decoy number versus the target number, our method dominantly
outperforms ProteinProphet in Figure 3(c)-(f).
Table 3: Running time of our program compared with ProteinProphet. The total running time
includes loading the peptide identification result, estimating protein probabilities and reporting
the final result.
Program ISB Sigma49 Human Yeast
ProteinInfer 0.340s 0.478s 1.057s 0.920s
ProteinProphet 14.273s 15.103s 16.473s 14.710s
All formulations of our method are closed-form. Thus, our method can calculate protein
probabilities efficiently. In Table 3, we show the running time of our method compared with
ProteinProphet. The comparison is conducted on a computer with 4GB memory and Intel(R)
Core(TM) i5-2500 CPU running the 32bit Windows 7 operating system. The final result shown
in the table is the average running time of ten runs. The total running time includes loading the
peptide identification result, estimating protein probabilities and reporting the result. The com-
parison of running time indicates the efficiency of our method in calculating protein probabilities.
According to the experimental results on four public available datasets, our method achieves
competitive performance with ProteinProphet in a more efficient manner.
The Parameter Issue
In the preprocessing step, there are two parameters λ1 and λ2 corresponding to the expected
number of unique peptides of true proteins and false proteins, respectively. These two parameters
are estimated empirically from data. Alternatively, these two parameters can be set manually.
Here, the performances of our method with different parameter settings are compared to show
whether our method is sensitive to the parameter setting.
In this section, we conduct our experiment on the ISB dataset and the Sigma49 dataset. These
two datasets have groundtruth, which reflects the impacts of parameter settings accurately.
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Table 4: Parameter settings. The default empirical parameter setting is marked with “*”. In the
experiment on each dataset, the performance based on the default parameter setting is shown for
reference.
Index ISB Sigma49
1
λ1 = 5
λ2 = 1
λ1 = 2
λ2 = 1
2
λ1 = 15
λ2 = 1
λ1 = 9
λ2 = 1
3
λ1 = 10
λ2 = 1
λ1 = 5
λ2 = 1
4
λ1 = 12
λ2 = 5
λ1 = 7
λ2 = 3
5
λ1 = 12
λ2 = 10
λ1 = 7
λ2 = 5
The empirical estimations of λ1 for the ISB dataset and the Sigma49 dataset are 12 and 7,
respectively. The parameter settings we consider are shown in Table 4. Under each parameter
setting, we use the curve of false positives versus true positives to measure the corresponding
performance of our method. The curve obtained by using the empirical parameters is taken as a
reference. We calculate the correlation of other curves with the reference to illustrate the perfor-
mance variation in different conditions. Figure 4 shows the results.
20
Figure 4: The performances of our method on the ISB dataset and the Sigma49 dataset under
different parameter settings shown in Table 4.
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In our model, we require that λ1 > λ2. We also conduct experiments to show what the result
is when parameters are misspecified (i.e. λ1 < λ2). The result is shown in Figure 5.
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Figure 5: The performances of our method when parameters are set as λ1 < λ2.
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According to the results in two figures, we can see that our method is not sensitive to the
parameter setting. The wrong parameter setting has a great impact on the protein identification
result. Thus, we do not allow λ1 < λ2 in our program.
More on Unique Peptide Probability Adjustment
From the previous experiment, we can see that our method is not sensitive to the parameter setting.
The only requirement is that parameters λ1 > λ2. According to Figure 4, the performances under
different parameters are close. Readers may be interested to know why we should adjust peptide
probabilities.
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Table 5: The protein probabilities of decoy proteins before and after peptide probability adjust-
ment. The last column is the rank position of the protein in the corresponding result. In the table,
PrD are 0.0000 because peptides of decoy proteins tend to be unique. According to our inequality
(18), PrL = PrU when all peptides are unique.
Probabilities Without Adjustment
Index Dataset Protein PrE PrD Rank
1 ISB decoy_499748 0.9971 0.0000 46
2 ISB decoy_237394 0.9243 0.0000 54
3 ISB decoy_224201 0.8864 0.0000 55
4 Sigma49 decoy_519997 0.9517 0.0000 62
5 Sigma49 decoy_170817 0.9417 0.0000 64
6 Sigma49 decoy_271930 0.8248 0.0000 74
Probabilities With Adjustment
Index Dataset Protein PrE PrD Rank
1 ISB decoy_499748 0.0650 0.0000 50
2 ISB decoy_237394 0.0024 0.0000 54
3 ISB decoy_224201 0.0016 0.0000 55
4 Sigma49 decoy_519997 0.2548 0.0000 72
5 Sigma49 decoy_170817 0.2190 0.0000 73
6 Sigma49 decoy_271930 0.0755 0.0000 77
Let us consider the top three decoys proteins in the experiments on the ISB dataset and the
Sigma49 dataset for the illustration purpose. Table 5 shows the protein probabilities of decoy
proteins before and after peptide probability adjustment. According to the result, the protein
probabilities of decoy proteins are decreased and they are ordered behind more target proteins.
Decoy proteins are representative of a kind of error in protein identification. It is not desired to
detect a decoy protein with a high confidence (e.g. decoy_499748 is detected with PrE = 0.9971
and PrD = 0.0000). In this sense, the protein identification result becomes more meaningful after
unique peptide adjustment. High confident decoy proteins are detected because its corresponding
decoy peptides are detected with high confidence. Since peptide probability calculation is not
perfect, we need to adjust it to achieve a more meaningful protein identification result.
In conclusion, unique peptide probability adjustment can improve the protein identification
result (i.e. decoys proteins are ranked behind more target proteins) and make the result more
meaningful than the result before adjustment. Thus, keeping the adjustment procedure in our
program is essential.
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Discussions and Conclusions
Protein Probability Interval
Protein probability interval PrD can be used to improve the distinction of protein identification
results as well as to filter protein identification results.
Table 6: The number of indistinguishable proteins based on probabilities without and with PrD.
Dataset Without PrD With PrD
ISB 27 21
Sigma49 38 36
Human 60 58
Yeast 181 178
Table 6 shows the numbers of indistinguishable proteins (based on the protein probability)
without and with PrD on four datasets. From the result, we can see that PrD decreases the number
of indistinguishable proteins.
Table 7: The number of subset proteins without and with PrD. In the table, “&&” means logical
“AND”.
Dataset PrE ≥ 0.9 PrE ≥ 0.9&&PrD ≤ 0.02
ISB 325 15
Sigma49 110 4
Human 12 4
Yeast 126 0
More importantly, PrD can be used as an extra filtering standard when PrE alone does not
work effectively. This is very useful in the case when subset proteins are considered (e.g. protein
identification rate is not satisfactory and homogeneous proteins are known to be present). Table
7 shows the number of subset proteins when using PrE ≥ 0.9 and PrE ≥ 0.9&&PrD ≤ 0.02 as
filters, respectively. Here, “&&” means logical “AND”. A great number of subset proteins can be
filtered out by using PrD. Thus, PrD and PrE form an effective filter to pick confident proteins.
More on the Distinction of Protein Identification Results
When calculating protein probabilities, we often find that many proteins are assigned with the
maximal score of one. The phenomenon can be explained with our model by considering the
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following example:
• Suppose a protein has three unique peptides with probabilities 0.97.
• The protein probability based on the three unique peptides is 1− (1−0.97)3 = 0.999973.
• Unique peptides are important to protein inference. According to equation (21), any ex-
tra identified peptides will further increase the confidence of the protein. Thus, we have
0.999973≤ PrE ≤ 1.0 and 0≤ PrD ≤ 0.000027. When only four decimal places are shown,
we will have PrE = 1.0000 and PrD = 0.0000. Actually, many proteins are assigned to prob-
ability 1.0 because small numeric errors are ignored.
The poor distinction is mainly caused by the ignorable numeric errors. Considering the impor-
tance of unique peptides in protein inference, the distinction can be improved by sorting pro-
teins with score one according to the number of unique peptides in descending order. The result
is shown in Figure 6. In the figure, the performance of “ProteinInfer+Unique” is obtained by
considering the number of unique peptides as an extra information in determining the order of
proteins. This trick can be used when reporting the protein identification result.
Figure 6: The performance of “ProteinInfer+Unique” is obtained by considering the number of
unique peptides as extra information in determining the order of proteins.
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However, this strategy does not work when two confident proteins have the same number of
unique peptides. The key factor in estimating distinct protein probabilities is the peptide prob-
ability calculation. Unique peptides are important to protein inference and degenerate peptides
will further increase the confidence of a protein. If the probability of a protein computed from
its unique peptide is high, the protein must be confident. Thus, we need to estimate peptide
probabilities conservatively especially for unique peptides.
Conclusion
In this paper, we propose a combinatorial perspective of the protein inference problem. From
this perspective, we obtain the closed-form formulations of the lower bound, the upper bound
and the empirical estimations of protein probability. Based on our model, we study an intrinsic
property of protein inference: unique peptides are important to the protein inference problem
and the impact of a degenerate peptide is determined by the number of times that the peptide is
shared. In our experiments, we show that our concise model achieves competitive results with
ProteinProphet.
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